A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial

Pediatric Diabetes

Volumn 16, Issue 4, 2015, Pages 263-270

  Baskaran, Charumathi ^a   Volkening, Lisa K ^a   Diaz, Monica ^a,b   Laffel, Lori M ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

Obesity; Overweight; Prevalence; T1D; Youth

Indexed keywords

HEMOGLOBIN A1C; ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHILD; CHILDHOOD OBESITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES CONTROL; DISEASE DURATION; EPIDEMIC; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 1; MULTIVARIATE ANALYSIS; OBESITY; UNITED STATES;

ADOLESCENT; BODY MASS INDEX; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; UNITED STATES;

EID: 84928828011     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12166     Document Type: Article

References (28)

1. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993: 329: 977-986.
2. Diabetes Control and Complications Trial Epidemiology of Diabetes Interventions and Complications (DCCT EDIC) Research Group, Nathan DM, Zinman B et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med 2009: 169: 1307-1316.
3. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006: 55: 1463-1469.
4. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 2001: 24: 1711-1721.
5. Katz ML, Volkening LK, Anderson BJ, Laffel LM. Contemporary rates of severe hypoglycaemia in youth with type 1 diabetes: variability by insulin regimen. Diabet Med 2012: 29: 926-932.
6. Brunelle BL, Llewelyn J, Anderson JH Jr, Gale EA, Koivisto VA. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998: 21: 1726-1731.
7. Murphy NP, Keane SM, Ong KK et al. Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens. Diabetes Care 2003: 26: 799-804.
8. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA 1998: 280: 140-146.
9. Purnell JQ, Zinman B, Brunzell JD. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 2013: 127: 180-187.
10. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012: 307: 483-490.
11. Olds TS, Tomkinson GR, Ferrar KE, Maher CA. Trends in the prevalence of childhood overweight and obesity in Australia between 1985 and 2008. Int J Obes (Lond) 2010: 34: 57-66.
12. Peneau S, Salanave B, Maillard-Teyssier L et al. Prevalence of overweight in 6- to 15-year-old children in central/western France from 1996 to 2006: trends toward stabilization. Int J Obes (Lond) 2009: 33: 401-407.
13. Kuczmarski RJ, Ogden CL, Guo SS et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 2002: 11: 1-190.
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004: 114: 555-576.
15. Knerr I, Wolf J, Reinehr T et al. The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9, 248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005: 48: 2501-2504.
16. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003: 26: 2871-2875.
17. Kaminski BM, Klingensmith GJ, Beck RW et al. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr 2013: 162: 736-740.
18. Liu LL, Lawrence JM, Davis C et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010: 11: 4-11.
19. Conway B, Miller RG, Costacou T et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med 2010: 27: 398-404.
20. Holl RW, Swift PG, Mortensen HB et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr 2003: 162: 22-29.
21. Retnakaran R, Hochman J, DeVries JH et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabetes Care 2004: 27: 2590-2596.
22. Paris CA, Imperatore G, Klingensmith G et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth Study. J Pediatr 2009: 155: 183-189.
23. Redondo MJ, Connor CG, Ruedy KJ et al. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes 2013[Epub ahead of print].
24. Miller KM, Beck RW, Bergenstal RM et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants. Diabetes Care 2013: 36: 2009-2014.
25. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel L. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001: 139: 197-203.
26. Driscoll KA, Johnson SB, Tang Y, Yang F, Deeb LC, Silverstein JH. Does blood glucose monitoring increase prior to clinic visits in children with type 1 diabetes? Diabetes Care 2011: 34: 2170-2173.
27. Pihoker C, Badaru A, Anderson A et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: the SEARCH for Diabetes in Youth Study. Diabetes Care 2013: 36: 27-33.
28. Klingensmith GJ, Miller KM, Beck RW et al. Racial disparities in insulin pump therapy and hemoglobin A1c (A1c) among T1D Exchange participants. Diabetes 2012: 61 (Suppl. 1): A358.